Montelukast Sodium Tablet, Coated
Product Images NDC 68084-875

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 68084-875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ahp87501

Ahp87501
FDA Label Image

Blister

Blister
FDA Label Image

Carton

Carton
Montelukast Sodium Tablets are tablets that contain 10 mg of montelukast and are intended for use by adults who are at least 15 years old. Each package contains 100 tablets (10 x 10) that are only available through prescription. The product should be stored at temperatures of 20° to 25°C (68° to 77°F), and should be protected from light and moisture. The package contains a medication guide that should be given to each individual. The drug has been produced by Dr. Reddy's Laboratories Inc. and distributed by American Health Packaging.*
FDA Label Image

Figure1 (Figure 1)

Figure1 (Figure 1)
This is a chart showing the change in height in centimeters over several weeks of treatment with Montelukast Sodium 5mg, Bechomethasone 336mg, and a Placebo. The chart includes data from 120 participants taking Montelukast, 119 taking Bechomethasone, and 121 taking the Placebo. The horizontal axis shows the weeks on treatment, with numbers ranging from -19 to 48. The vertical axis represents the change in height, with numbers ranging from -16 to 48.*
FDA Label Image

Figure2 (Figure 2)

Figure2 (Figure 2)
The text represents a graph showing the mean percentage change from baseline for a treatment over several weeks. The treatment consists of either a placebo or Montelukast Sodium. The graph displays the results at week 0, 3, 6, 9, 12, and 15. A period of washout is also included in the graph.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.